A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Dec, 5, 2016 -- Aytu Bioscience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global...
Presentation on Thursday, December 8th at 9:30 AM PTENGLEWOOD, Colo., Dec. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh...
Natesto Improves All Five Domains of Erectile FunctionENGLEWOOD, Colo., Nov. 30, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the summary...
Company invites individual and institutional investors to attend interactive real-time virtual VirtualInvestorConferences.comENGLEWOOD, Colo., Nov. 28, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization...
Data Establishes a Clear Protocol for Reproducible Sampling and a Clinical Cut-Off Value for Distinguishing Infertile MenENGLEWOOD, Colo., Nov. 17, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of...
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 7, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today an overview of...
Live Conference Call and Webcast Scheduled for November 7, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 3, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology,...
ENGLEWOOD, Colo., Nov. 2, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the closing of its previously announced underwritten public...
Presents Clinical Findings at 72nd Annual Meeting of the American Society of Reproductive MedicineENGLEWOOD, Colo., Nov. 1, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the...
ENGLEWOOD, Colo., Sept. 14, 2016 -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at two upcoming investor conferences in...